IA melhora em 22% precisão do diagnóstico de câncer de mama

[{"selector":"#anim-a662ed40-1dfc-4625-ae96-0de6f9cb018f","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-50cbc634-3eaa-44b3-9dbe-57dddeec8275","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1725b485-cd6d-4789-8e66-2e1429cd25ae","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-d09f39dc-d4e4-4901-b299-4292f89cb716","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Anna Tarazevich/Pexels

[{"selector":"#anim-de0c7af3-9348-4edc-9ba2-df09580d06c9","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c12c30f7-37ac-4c2a-be76-6738a089a1d5","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b42c1cd1-c235-47e9-b33a-a94a9b3cf0df","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-9ed557e6-8f97-4073-be4f-86c60a2a1cd9","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Um novo estudo mostrou que o uso de inteligência artificial (IA) pode aumentar a precisão no diagnóstico de câncer de mama em 22%. O trabalho envolveu pesquisadores de 10 países, incluindo o Brasil Freepik

[{"selector":"#anim-99d4b189-83c8-41bc-9dd3-386eafa108e3","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6f107585-9e89-431b-b00a-15ab9e029e79","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c38fb9f7-e029-4ce5-a5a3-456f62ea60cb","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-906844a8-82c0-4f03-8339-faa36ae5fecf","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Ivan Samkov/Pexels A pesquisa focou em um grupo de pacientes que representa a maioria dos casos de câncer de mama: HER2-baixo ou HER2-ultrabaixo

[{"selector":"#anim-4c2cdf55-ef89-4a77-822b-88b4cb3a2c9d","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b65df1d8-84a6-4bec-9d18-54682068e137","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-847479b5-6a70-4559-9383-775d3675af3e","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-adf2b868-23f5-4f3f-87d6-b07fb6a8182b","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Freepik Esses são casos de tumores que apresentam algum nível de expressão da proteína HER2, que desempenha um papel crucial no crescimento e desenvolvimento celular. Tumores com altos níveis de HER2 (chamados HER2-positivos) podem ser mais agressivos

[{"selector":"#anim-135aadc3-897f-47f6-b704-103e06cac58b","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2296db23-4631-4469-96a5-e890248a3df9","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a91aa720-2412-42bd-8c57-3e0a047d2d80","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-8698c7ba-00f8-4ee4-aebc-087c4bd4e657","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] VAZHNIK/Pexels Para realizar o estudo, os pesquisadores utilizaram uma plataforma digital de treinamento assistida por IA chamada ComPath Academy para avaliar 20 amostras digitais de câncer de mama

[{"selector":"#anim-a55ef703-73fa-48f9-974d-0a6e234e7bc5","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e3f104d3-c42a-4667-8942-62c10999528d","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d6904228-7d36-495e-85f8-5608d1ee3cbc","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-50dfee64-bbcb-44f1-9eaf-a8940cc6ba81","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] O estudo mostrou que a IA aumentou a sensibilidade do diagnóstico de, aproximadamente, 76% para 90%. Além disso, a precisão geral na categorização dos casos aumentou de 66,7% para 88,5% Cristine Rochol/PMPA

[{"selector":"#anim-982a9a53-2ebb-4aaf-9a29-dddd853de24d","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-585b6490-29c4-4e2a-b1f8-83b530f0aa7b","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e346d8cb-10a2-4e8f-a64a-d29134e21376","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-dda845aa-3b79-4f15-994e-069f680f3ef9","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Por fim, a IA reduziu em mais de 25% os casos de HER2-ultrabaixo incorretamente classificados como HER2-nulos Cristine Rochol/PMPA

CNNBRASIL.COM.BR

[{"selector":"#anim-d93167a7-226a-4707-abab-46b74a97fe1c","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9858e295-81db-4c53-b3f2-fff6ad654384","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-bf7ccf4d-f959-42dd-a162-952e51e962ad","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-076898d0-24ad-4686-9f00-4897a8930962","keyframes":{"transform":["translate3d(0px, 2088.88644%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ae90a945-7d3f-496a-afa3-9f230823b69c","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-3af75666-8be6-4908-b3b6-8dd6e569f4db","keyframes":{"transform":["translate3d(-117.84387%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a80792f5-55ae-4e47-86bb-2870cb4382df","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6540d68e-30b3-47d3-b783-af8ab8e6e4d3","keyframes":{"transform":["translate3d(0px, 1223.93157%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] leia mais em Klaus Nielsen/Pexels